Quality Inspector II 3rd Shift jobs in United States
cer-icon
Apply on Employer Site
company-logo

Synergetics ยท 1 day ago

Quality Inspector II 3rd Shift

Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight. The MQA Line Inspector is responsible for performing quality inspections for finished and contract goods, ensuring compliance with regulations and assisting in quality decisions for nonconforming products.

Health CareHealth DiagnosticsManufacturingMedical DevicemHealth
badNo H1Bnote

Responsibilities

Utilizes statistical sampling plans to perform visual and functional inspections of contract and Greenville finished product
Documents all results in the QA batch record or on the Receiving Inspection Report
Assists in quality decisions for nonconforming product and provides QA inspection support to the Manufacturing operation
Assists in the Investigation and documentation of process issues that occur during the production operation including input to in-process product quality decisions
Maintains retain sample inventory for all finished product

Qualification

Quality inspectionStatistical samplingDimensional inspectionComputer skillsCommunication skills

Required

High School Diploma required
2-3 years prior manufacturing or inspection experience required
Prior exposure to visual and dimensional inspection required

Preferred

Previous inspection experience using balances and dimensional tools preferred
Computer skills using MS Excel, MS Word, MS Outlook, MS Access, Warehouse Management System (ERPLX) and Document Management System (Documentum)
Excellent written and verbal communication skills demonstrated
Good people skills
Must be able to communicate with a cross functional team and management concerning quality issues
Decision-making ability and ability to work unsupervised expected

Benefits

Employee Benefits: Bausch + Lomb

Company

Synergetics

twittertwittertwitter
company-logo
As Synergetics becomes Bausch + Lomb Retina, keep following us to learn why our newly formed partnership is all about you.

Funding

Current Stage
Public Company
Total Funding
unknown
2016-02-10Acquired
1990-04-06IPO
Company data provided by crunchbase